Literature DB >> 33766163

Prevalence of depressive symptoms among Chinese university students amid the COVID-19 pandemic: a systematic review and meta-analysis.

Wei Luo1, Bao-Liang Zhong1,2, Helen Fung-Kum Chiu3.   

Abstract

AIMS: Chinese university students are at high risk for depressive symptoms and the ongoing coronavirus disease 2019 (COVID-19) pandemic may have exacerbated the mental health of university students. However, existing studies on depressive symptoms in Chinese university students during the COVID-19 pandemic reported a wide range of prevalence estimates, making mental health planning for this population difficult. The objective of this study was to conduct a systematic review and meta-analysis of surveys that assessed the prevalence of depressive symptoms in Chinese university students amid the COVID-19 pandemic.
METHODS: Major Chinese (CNKI, Wanfang, VIP) and English (PubMed, Embase, PsycInfo) databases and preprint platforms were searched to identify cross-sectional studies containing data on the prevalence of depressive symptoms in Chinese university students during the pandemic. Two authors independently retrieved the literature, evaluated the eligibility of potential studies, assessed the risk of bias (RoB) of included studies, and extracted data. RoB was assessed with the Joanna Briggs Institute Critical Appraisal Checklist for Studies Reporting Prevalence Data.
RESULTS: In total, 1177 records were retrieved, and 84 studies involving 1 292 811 Chinese university students during the pandemic were included. None of the included studies were rated as completely low RoB. Statistically significant heterogeneity in the prevalence estimates of included studies was detected (I2 = 99.9%, p < 0.001). The pooled prevalence of depressive symptoms was 26.0% (95%CI: 23.3-28.9%), which was significantly higher in female than in male students (30.8% v. 28.6%, p < 0.001), in postgraduates than in undergraduates (29.3% v. 22.9%, p < 0.001), in students living inside than in those living outside the COVID-19 epicentre (27.5% v. 22.3%, P < 0.001), in students from universities at the epicentre than in those from universities outside the epicentre (26.2% v. 23.1%, p < 0.001), in students who had close contact with COVID-19 than in those who did not (46.0% v. 25.0%, p < 0.001), and in students who had acquaintances or relatives infected with COVID-19 (39.7% v. 24.0%, p < 0.001) than in those who did not. Five sources of heterogeneity were identified from the subgroup analysis: survey period, % of males among the survey sample, scale of depressive symptoms, cutoff score of the scale and level of RoB.
CONCLUSIONS: Over one-fourth of Chinese university students experienced depressive symptoms during the COVID-19 pandemic. Mental health services for this population should include periodic evaluation of depressive symptoms, expanded social support and psychiatric assessment and treatment when necessary. It is also necessary to design depression prevention programmes that target higher-risk cohorts of university students.

Entities:  

Keywords:  COVID-19; depressive symptoms; meta-analysis; prevalence; systematic review; university students

Year:  2021        PMID: 33766163     DOI: 10.1017/S2045796021000202

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  33 in total

1.  Prevalence and Correlates of Mental Health of University Students in Hong Kong: What Happened One Year After the Occurrence of COVID-19?

Authors:  Daniel T L Shek; Diya Dou; Xiaoqin Zhu
Journal:  Front Public Health       Date:  2022-06-29

2.  The Relationship Between Postgraduates' Emotional Intelligence and Well-Being: The Chain Mediating Effect of Social Support and Psychological Resilience.

Authors:  Zhang Shuo; Deng Xuyang; Zhao Xin; Cai Xuebin; Hou Jie
Journal:  Front Psychol       Date:  2022-06-14

3.  Level of Depression during the COVID-19 Pandemic in Poland-A Cross-Sectional Study.

Authors:  Anna Zalewska; Monika Gałczyk; Katarzyna Van Damme-Ostapowicz
Journal:  Healthcare (Basel)       Date:  2022-06-16

4.  Mental Health Among Medical Students During COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Qingwen Jia; Yi Qu; Huiyuan Sun; Huisheng Huo; Hongxia Yin; Dianping You
Journal:  Front Psychol       Date:  2022-05-10

5.  Prevalence and Unmet Need for Mental Healthcare of Major Depressive Disorder in Community-Dwelling Chinese People Living With Vision Disability.

Authors:  Bao-Liang Zhong; Yan-Min Xu; Yi Li
Journal:  Front Public Health       Date:  2022-06-22

6.  The Association Between Cyberbullying Victimization and Suicidal Ideation Among Chinese College Students: The Parallel Mediating Roles of Core Self-Evaluation and Depression.

Authors:  Xiaowei Chu; Sumin Yang; Zhaoxing Sun; Min Jiang; Ruibo Xie
Journal:  Front Psychiatry       Date:  2022-06-30       Impact factor: 5.435

7.  Anaemia prevalence and its associated factors in children under 5 years in Western China: a systematic review.

Authors:  Yefan Du; Ying Liao; Fangqun Leng; Linhua Li; Ruixue Ye; Yuping Mao; Hein Raat; Huan Zhou
Journal:  BMJ Paediatr Open       Date:  2022-01

8.  Training of psychiatry and mental health in a low- and middle-income country: Experience from Thailand before and after COVID-19 outbreak.

Authors:  Rasmon Kalayasiri; Sorawit Wainipitapong
Journal:  Asia Pac Psychiatry       Date:  2021-12-07       Impact factor: 2.538

Review 9.  Understanding the psychiatric symptoms of COVID-19: a meta-analysis of studies assessing psychiatric symptoms in Chinese patients with and survivors of COVID-19 and SARS by using the Symptom Checklist-90-Revised.

Authors:  Qin Xie; Xiao-Bo Liu; Yan-Min Xu; Bao-Liang Zhong
Journal:  Transl Psychiatry       Date:  2021-05-17       Impact factor: 6.222

10.  More Depressive Symptoms, Alcohol and Drug Consumption: Increase in Mental Health Symptoms Among University Students After One Year of the COVID-19 Pandemic.

Authors:  Ezgi Dogan-Sander; Elisabeth Kohls; Sabrina Baldofski; Christine Rummel-Kluge
Journal:  Front Psychiatry       Date:  2021-12-16       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.